INS and type 2 diabetes mellitus: (BJSME) significantly improved the oral glucose tolerance and insulin tolerance, increased the number of pancreatic islets, and reduced fat and liver mass, adipose accumulation in liver, blood glucose, and related blood-lipid content without altering body weight and food intake in T2DM mice.